Selecting the optimal Asian countries in which to establish or expand a clinical trial depends on the unique goals and priorities of each sponsor, as well as the indication and type of treatment being developed. That’s why companies from emerging biotech start-ups to the largest pharmaceutical players have engaged CRO partners with in-depth knowledge of the Asian landscape. For more information, please download this free white paper.